| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Herpes Simplex Virus Type 1 and Type 2, IgG
MessagePerforming Lab: Methodist Hospital
Test Code
LABS20471
Alias/See Also
Sunquest;HSVGT
EPIC;LABS20471
EPIC;LABS20471
CPT Codes
HSV1=86695 HSV2=86696
Preferred Specimen
Serum collected in Serum Spearator Tube or Plain Red Top
Transport Temperature
Refrigerated
Specimen Stability
Refrigerated: 7 days
Frozen: More than 7 days
Frozen: More than 7 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Specimens other than Serum. Specimens exhibiting gross (4+) hemolysis, icterus or lipemia.
Methodology
Semi Quantitative Chemiluminescent Immunoassay
Setup Schedule
Monday - Friday
Report Available
Monday - Friday
Reference Range
HSV-1 Type specific IgG
HSV-2 Type Specific IgG
Note: The magnitude of the reported Index is not indicative of the amount of antibody present in the patient sample.
Seroconversion from a negative sample to a positive sample is evidence of either a recent infection or an acute infection. A positive result generally indicates exposure to HSV
Additional Information:
1. Serological cross-reactivity has been noted in specimens containing antibody to Treponema pallidum and Candida albicans.
2. Assay results should be used in conjunction with other clinical and laboratory data to assist the clinician in making individual patient management decision.
3. The performance of this assay has not been established for monitoring HSV-1 therapy.
4. Grossly hemolyzed, icteric or lipemic samples, as well as samples containing particulate matter or exhibiting obvious bacterial contamination should not be tested.
| Index | Results | Interpretation |
| <0.9 | Negative (No further testing) | No detectable antibodies to HSV-1 were found. A negative result generally indicates that the patient has not been infected, but does not always rule out acute HSV infection. If clinical exposure to HSV is suspected despite a negative finding, a second sample should be collected and tested no less than 4-6 weeks later. |
| 0.9-1.10 | Equivocal | If equivocal, a second sample should be collected no less than 4-6 weeks later. |
| Greater than or equal to 1.10 | Positive (No further testing) | Indicates the presence of detectable IgG antibody to HSV-1 |
HSV-2 Type Specific IgG
| Index | Results | Interpretation |
| <0.9 | Negative (No further testing) | No detectable antibodies to HSV-2 were found. A negative result generally indicates that the patient has not been infected, but does not always rule out acute HSV infection. If clinical exposure to HSV is suspected despite a negative finding, a second sample should be collected and tested no less than 4-6 weeks later. |
| 0.9-1.10 | Equivocal | If equivocal, a second sample should be collected no less than 4-6 weeks later. |
| Greater than or equal to 1.10 | Positive (No further testing) | Indicates the presence of detectable IgG antibody to HSV-2 |
Note: The magnitude of the reported Index is not indicative of the amount of antibody present in the patient sample.
Seroconversion from a negative sample to a positive sample is evidence of either a recent infection or an acute infection. A positive result generally indicates exposure to HSV
Additional Information:
1. Serological cross-reactivity has been noted in specimens containing antibody to Treponema pallidum and Candida albicans.
2. Assay results should be used in conjunction with other clinical and laboratory data to assist the clinician in making individual patient management decision.
3. The performance of this assay has not been established for monitoring HSV-1 therapy.
4. Grossly hemolyzed, icteric or lipemic samples, as well as samples containing particulate matter or exhibiting obvious bacterial contamination should not be tested.
